Fiduciary Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-324
Closed -$348K 84
2025
Q4
$348K Buy
324
+4
+1% +$3.83K 0.14% 63
2025
Q3
$244K Buy
320
+68
+27% +$50.6K 0.1% 77
2025
Q2
$197K Sell
252
-12
-5% -$9.32K 0.19% 48
2025
Q1
$218K Buy
+264
New +$220K 0.19% 38

Other funds holding LLY

Fiduciary Wealth Partners's LLY Position: Q1 2026 in Review

Fiduciary Wealth Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 324 shares — an estimated $348K sold.

Fiduciary Wealth Partners first reported a position in LLY in Q1 2025 and held it in 4 quarters. The position peaked at $348K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fiduciary Wealth Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Fiduciary Wealth Partners sold 324 Eli Lilly shares in Q1 2026, an estimated $348K.
  • Fiduciary Wealth Partners first reported a position in Eli Lilly in Q1 2025 and held it in 4 quarters.
  • Fiduciary Wealth Partners's Eli Lilly position peaked at $348K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.